Endocrinology
Conference Coverage
Take drug, patient-level factors into account for when to end antiresorptive therapy
LAS VEGAS – The agent and individual patient factors may affect the duration of treatment and the approach to resuming therapy.
Conference Coverage
Multiple zoledronic acid doses may be needed after stopping denosumab
ORLANDO – An ongoing, randomized study finds that after 1 year about one-third of patients with osteopenia have needed readministration of...
Conference Coverage
Romosozumab benefits osteoporosis patients regardless of renal insufficiency
ORLANDO – Romosozumab (Evenity) did not noticeably affect increases in BMD or lowered vertebral fracture incidence among patients with various...
Conference Coverage
Consider cognitive reframing of osteoporosis to improve adherence
ORLANDO – Counter negative patient perceptions about osteoporosis treatment by explaining the risks of treatment with medications as well as the...
Conference Coverage
Osteoporosis remains a costly burden to older U.S. adults
ORLANDO – Older women and minorities continue to bear the brunt of the burden of fragility fractures in the United States.
Latest News
Panel releases guidelines for red meat, processed meat consumption
"This assessment may be excessively pessimistic; indeed, we hope that is the case," the panel said.
News
FDA adds diabetic kidney disease, heart failure indications to canagliflozin
This marks the first time in 20 years that a drug has been indicated for diabetic kidney disease treatment, according to the manufacturer.
Conference Coverage
Vitamin D does not improve bone density, structure in healthy patients
ORLANDO – Daily use for 2 years did not affect areal BMD in the whole body, femoral neck, total hip, or spine, or...
Conference Coverage
Machine learning–derived risk score predicts heart failure risk in diabetes patients
Highest WATCH-DM scores linked to 5-year heart failure risk approaching 20%.
Conference Coverage
Project ECHO helps osteoporosis specialists connect with PCPs
ORLANDO – Health care providers who participated in the ECHO program became more confident in 20 different domains...
Guidelines
Try testosterone for some women with sexual dysfunction, but not others
Evidence does not support testosterone use for other conditions, and concentrations should mirror premenopausal physiological conditions.